Literature DB >> 21603831

Pseudoporphyria induced by dialysis treated with oral N-acetylcysteine.

Marcelo Massaki Guiotoku1, Fabíola de Paula Pereira, Hélio Amante Miot, Mariângela Esther Alencar Marques.   

Abstract

Pseudoporphyria is a rare bullous dermatosis that clinically and histopathologically is similar to porphyria cutanea tarda. It mainly affects patients with chronic renal failure on peritoneal dialysis or hemodialysis. Medications can also be involved in the etiology. Diagnosis and management of this condition is a challenge for dermatologists. The authors report a case of pseudoporphyria related to dialysis with favorable outcome after the use of oral N-acetylcysteine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21603831     DOI: 10.1590/s0365-05962011000200031

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  4 in total

1.  Pseudoporphyria in a peritoneal dialysis patient.

Authors:  Arzu Velioglu; Tulin Ergun; Cetin Ozener
Journal:  Perit Dial Int       Date:  2015 Mar-Apr       Impact factor: 1.756

2.  Drug induced pseudoporphyria in CKD: A case report.

Authors:  S Quaiser; R Khan; A S Khan
Journal:  Indian J Nephrol       Date:  2015 Sep-Oct

3.  Pseudoporphyria induced by hemodialysis.

Authors:  Beata Bergler-Czop; Ligia Brzezińska-Wcisło
Journal:  Postepy Dermatol Alergol       Date:  2014-02-25       Impact factor: 1.837

4.  Pseudoporphyria associated with nonhemodialyzed renal insufficiency, successfully treated with oral N-acetylcysteine.

Authors:  A C Katoulis; D Ferra; E Toumbis; E Papadavid; A Kanelleas; I Panayiotides; D Rigopoulos
Journal:  Case Rep Dermatol Med       Date:  2013-04-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.